Evidence of neuroplasticity with robotic hand exoskeleton for post-stroke rehabilitation: a randomized controlled trial.
Neha Singh, Megha Saini, Nand Kumar and 2 others
PMID 33957937WHAT IT FOUND
Robotic exoskeleton therapy improved wrist spasticity, movement range, and hand function more than conventional physiotherapy in stroke patients.
Brain scans showed increased excitability in the injured hemisphere, suggesting neuroplasticity. This is a small pilot, so confirm with larger trials before changing practice.
Key findings
01The robotic group showed significantly greater reduction in wrist spasticity and greater improvement in active range of motion and hand function scores compared to the conventional therapy group.
02Only the robotic group showed significant changes in brain excitability markers, with motor thresholds decreasing and motor evoked potentials increasing in the injured hemisphere.
03In five robotic patients who initially had no measurable brain response to stimulation, the response appeared after therapy alongside substantial functional gains.
STILL TO COME
How it was doneWhat they foundWhat it means for PTsWhat it means for OTs
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
Very small sample size (23 patients analysed), making the results preliminary and prone to chance. The therapist delivering the interventions was not blinded to the group allocation, which could bias outcomes. No long-term follow-up to determine if the gains in function and brain excitability were sustained. The control group received conventional physiotherapy, but the specific content was not standardized beyond duration, so comparisons may be affected by variability in conventional care. The device is a prototype, so the findings may not generalize to commercially available robotic systems.
Declared interests
Funded by the Indian Institute of Technology Delhi and the Science and Engineering Research Board. No commercial conflicts of interest were declared, but the authors developed the device.
The easy way to misread this
Do not interpret the neuroplasticity findings as proof that this specific prototype device is clinically superior for all stroke patients. The study was a small pilot with no long-term follow-up, and the brain changes were correlated with, not proven to cause, the functional gains. Larger, blinded trials are needed before this technology changes standard rehabilitation protocols.